Gain Therapeutics' GT-02287 shows promising efficacy and safety data, targeting both idiopathic and GBA1 Parkinson’s disease, with potential for substantial market impact and investor gains. The ...
Existing research indicates that the accuracy of a Parkinson's disease diagnosis hovers between 55% and 78% in the first five years of assessment. That's partly because Parkinson's sibling movement ...
Existing research indicates that the accuracy of a Parkinson’s disease diagnosis hovers between 55% and 78% in the first five years of assessment. That’s partly because Parkinson’s sibling movement ...
When most people think of Parkinson’s disease (PD), the image of trembling hands or slowed movements often comes to mind. However, experts stress that these visible signs are only part of the story.
People with autism had a higher risk of developing Parkinson's disease early in life. The risk of Parkinson's before age 50 was four times higher in people with versus without autism. A Parkinson's ...
Early detection of even the slightest motor function changes can be critical to slowing the progression of Parkinson's disease. Yet these subtle signs often go unnoticed. Now, UF researcher Diego L.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results